DATA GRAPHICS | Data Byte
New mechanisms enter the Cushing disease pipeline
The fourth disease-modifying therapy is nearing the market
November 19, 2021 11:48 PM UTC
At least three drugs for Cushing disease targeting three different points in the cortisol pathway are on the market, and a fourth is under review, but companies are still finding new points of intervention for the hormone disorder.
Cushing disease, a form of Cushing syndrome, is a hormone disorder characterized by high levels of cortisol in the blood caused by ACTH-secreting pituitary adenomas...